Jacobio Pharma

Jacobio Pharma is a dynamic clinical-stage oncology company dedicated to researching and developing innovative solutions to address previously undruggable targets. With a focus on improving human health, Jacobio Pharma operates at the forefront of biotechnology research, driving advancements in the treatment of cancer. The company's robust pipeline targets key molecular pathways, positioning Jacobio Pharma as a leader in the global pharmaceutical landscape.

Operating from its state-of-the-art R&D centers in Beijing, Shanghai, and Boston, Jacobio Pharma leverages its proprietary Induced Allosteric Drug Discovery Platform (IADDP) and iADC Platform to create groundbreaking therapies. Jacobio Pharma is committed to becoming a global leader recognized for its significant impact on drug research and development through strategic partnerships and innovative approaches. The primary address for Jacobio Pharma is 北京市北京经济技术开发区经海三路105号院8号楼 北京市, 北京市 101111, CN, with an additional location at 99 Hayden Ave, Lexington, Massachusetts 02421, US.

Jacobio Pharma's commitment extends to advancing oncology treatments and ensuring that key projects are among the top three in the world. Jacobio Pharma aims to make a lasting impact on global health through continuous innovation and strategic collaborations. We invite the management team at Jacobio Pharma to create a customized and exclusive company showcase and product listing on our platform, further amplifying their market presence and connecting with potential partners and customers.